25796-97-8 Usage
Uses
Used in Organic Synthesis:
2,3-DiMethyl-1H-pyrrolo[2,3-c]pyridine is used as a building block for the synthesis of various organic compounds and pharmaceuticals. Its unique structure and reactivity make it a valuable component in creating new molecules with potential applications in medicine and other fields.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,3-DiMethyl-1H-pyrrolo[2,3-c]pyridine is used as a precursor in the preparation of several biologically active molecules. Its role in the development of new drugs is crucial, as it can be incorporated into the molecular structures of potential therapeutic agents.
Used in Research Applications:
2,3-DiMethyl-1H-pyrrolo[2,3-c]pyridine is used as a chemical reagent in research settings, where its unique properties are leveraged to explore new chemical reactions and pathways. This contributes to the advancement of knowledge in organic chemistry and the discovery of novel synthetic methods.
Used in Industrial Applications:
In industrial applications, 2,3-DiMethyl-1H-pyrrolo[2,3-c]pyridine is utilized for its versatility and reactivity, enabling the production of a wide range of chemical products. Its use in industrial processes highlights its practical value in creating commercially relevant compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 25796-97-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,7,9 and 6 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 25796-97:
(7*2)+(6*5)+(5*7)+(4*9)+(3*6)+(2*9)+(1*7)=158
158 % 10 = 8
So 25796-97-8 is a valid CAS Registry Number.
25796-97-8Relevant academic research and scientific papers
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate
Harcken, Christian,Riether, Doris,Liu, Pingrong,Razavi, Hossein,Patel, Usha,Lee, Thomas,Bosanac, Todd,Ward, Yancey,Ralph, Mark,Chen, Zhidong,Souza, Donald,Nelson, Richard M.,Kukulka, Alison,Fadra-Khan, Tazmeen N.,Zuvela-Jelaska, Ljiljana,Patel, Mita,Thomson, David S.,Nabozny, Gerald H.
supporting information, p. 1318 - 1323 (2015/01/09)
A series of nonsteroidal dissociated glucocorticoid receptor agonists was optimized for drug-like properties such as cytochrome P450 inhibition, metabolic stability, aqueous solubility, and hERG ion channel inhibition. This effort culminated in the identification of the clinical candidate compound (R)-39.
1,1,1-TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO
-
Page/Page column 192, (2010/02/11)
Compounds of Formula (IA), IB), IC), and (ID) wherein R1, R2, R3, R4, R5, and R6 are as respectively defined herein for Formula (IA), (IB), (IC), and (ID), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
